What is the main business of Coopervision Poland?

The main business activity of Coopervision Poland focuses on wholesale of pharmaceutical goods.

When was the company founded?

The company was registered in the Polish National Court Register (KRS) on June 10, 2013.

Where is the headquarters located?

The headquarters is located at: ul. Domaniewska 44, 02-672 Warszawa.

What is the share capital?

The share capital of the company is PLN 3,505,000 (approx. $946,786).

What period do the latest financial data cover?

The latest available financial statement covers the period from November 1, 2024 to October 31, 2025.

What was the revenue?

In 2025, the company generated total revenue of USD 22,928,420, representing an increase of 0.9% compared to 2024.

Yes, in 2025 the company was profitable, achieving a net profit of USD 521,174, meaning the company increased its profit by 0.1%.

What is the largest operating cost?

The largest operating cost category falls under cost of goods and materials sold. This category amounted to USD 19,055,967 in 2025, representing 86% of all operating expenses.

Coopervision Polandsp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status

Active

Registry date

2013-06-10

Share capital

3,505,000.00 PLN

Activity description

Coopervision Poland offers daily and monthly soft contact lenses, including Biofinity, MyDay and MiSight 1 day. Its products include spherical, toric and multifocal lenses, as well as MiSight 1 day lenses for myopia control.

Registered address

ul. Domaniewska 44, 02-672 Warszawa, Poland

Website

coopervision.pl

Financials

Revenue history (in m)

Filing timeliness

6 of 6 financial statements were filed late (the longest delay 1523 days for 2020). 3 of 6 audited by a statutory auditor.

202502/10/2026
202402/10/2026
202311/06/2026
202208/06/2026
202124/10/2025
202016/10/2025

Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue

This companyUSD 22.93mMedianUSD 1.06mAverageUSD 22.41m

Net profit

This companyUSD 521.17kMedianUSD 37.20kAverageUSD 879.46k

Operating costs

This companyUSD 22.23mMedianUSD 921.66kAverageUSD 21.08m

Assets

This companyUSD 7.18mMedianUSD 609.79kAverageUSD 11.85m

Industry

Offer

Daily contact lenses
Monthly contact lenses
Toric contact lenses
Multifocal contact lenses
Contact lenses for children

Website technology

Analytics and marketing

Google Tag Manager

Authorized Representatives

Agostino Ricupati – Management Board Member

Brian George Andrews – Management Board Member

Richard Michael Cheshire – Management Board Member

Deborah Olive – Management Board Member

Manner of representation

The company is represented by two members of the management board acting jointly.

Ownership

Owner	Shares	Share value	Stake
Coopervision Limited	70,100	$946,785.52	100%

Beneficial owners

Person	Rights

Bank accounts

Registered as a VAT taxpayer on 2013-06-17.

Citi Handlowy (Bank Handlowy w Warszawie)
21 1030 1508 0000 0008 1700 1009

Debt

1 closed proceeding recorded in KRZ history.

Registration date	Proceeding type	Status
Oct 3, 2023	Discontinued enforcement proceedings	Closed

Public aid

No public aid cases recorded in the last 10 years.

Competitors

Name	Revenue	Website
Consultronixsp. z o.o.	$29,089,133.20	consultronix.pl
JAI Kudo Polskasp. z o.o.	$20,518,471.90	jaikudo.pl
Ursapharm Polandsp. z o.o.	$16,296,973.60	ursapharm.pl
Simply You Polandsp. z o.o.	$7,463,283.82	simply-you.pl
Profimedsp. z o.o.	$4,109,286.04	profimed.com
Sunewmed+ Polandsp. z o.o.	$3,668,651.65	sunew.pl

Change history

Date	Event
2019-08-23	Address change (Ul. Przemysława Gintrowskiego 53, 02-697, Warszawa → Ul. Domaniewska 44, 02-672, Warszawa)
2018-03-14	Address change (Rzymowskiego 53, 02-697, Warszawa → Ul. Przemysława Gintrowskiego 53, 02-697, Warszawa)
2016-06-09	PKD change (Removed: 21, 26, 32, 68, 70.10.Z, 77)
2014-01-17	Share capital increase (5,000.00 PLN → 3,505,000.00 PLN)
2013-10-28	Address change (Al. Jerozolimskie 56 C, 00-803, Warszawa → Rzymowskiego 53, 02-697, Warszawa)

FAQ

Last updated: 2026-10-07